Publications by authors named "Thomas Dahl"

Claim this Profile
T
The efficacy of a combination of naproxen and fexofenadine (SJP - 002) to inhibit the symptoms that are associated with viral upper respiratory tract infection: Four case reports of individuals with common cold.
Emina Išerić, Thomas A Dahl, Andrew Scholey, Jacqueline M Iversen, Joris C Verster

Clin Case Rep· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Naproxen/Fexofenadine (SJP-003) in the Prevention of Side Effects of Influenza Vaccination: Four Case Studies.
Pantea Kiani, Thomas A Dahl, Jacqueline M Iversen, Andrew Scholey, Joris C Verster

Clin Pract· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of the triple-combination SM-1 in a 5-h phase advance transient insomnia model.
Thomas Dahl, Gary Zammit, Maha Ahmad, Russell Rosenberg, Lan Bo Chen

Sleep Biol Rhythms· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional observation after morphine withdrawal: effects of SJP-005.
Joris C Verster, Andrew Scholey, Thomas A Dahl, Jacqueline M Iversen

Psychopharmacology (Berl)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro Assessment of the Antiviral Activity of Ketotifen, Indomethacin and Naproxen, Alone and in Combination, against SARS-CoV-2.
Pantea Kiani, Andrew Scholey, Thomas A Dahl, Lauren McMann, Jacqueline M Iversen

Viruses· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comparison of the Antinociceptive Properties of SJP-005 and Morphine in Rats.
Joris C Verster, Andrew Scholey, Thomas A Dahl, Jacqueline M Iversen

Pharmaceutics· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effects of SJP-001 on Alcohol Hangover Severity: A Pilot Study.
Joris C Verster, Thomas A Dahl, Andrew Scholey, Jacqueline M Iversen

J Clin Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic and pharmacokinetic profile of SM-1, a triple-drug combination to increase total sleep time.
Thomas Dahl, Lan Bo Chen, Mika Scheinin, Jaana Suopanki-Lalowski, Marju Valge

Hum Psychopharmacol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of SM-1 in a transient insomnia model.
Thomas Dahl, Lan Bo Chen, Gary Zammit, Maha Ahmad, Thomas Roth

Hum Psychopharmacol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potentiation of azole antifungals by 2-adamantanamine.
Michael D Lafleur, Lingmei Sun, Ida Lister, John Keating, Andre Nantel, Thomas Dahl

Antimicrob Agents Chemother· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of individual factors and school environment on mental health and prejudiced attitudes among Norwegian adolescents.
Helle Wessel Andersson, Johan Håkon Bjørngaard, Silje Lill Kaspersen, Catharina E A Wang, Ingunn Skre, Thomas Dahl

Soc Psychiatry Psychiatr Epidemiol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I clinical trial of STA-4783 in combination with paclitaxel in patients with refractory solid tumors.
Anna Berkenblit, Joseph P Eder, David P Ryan, Michael V Seiden, Noriaki Tatsuta, Thomas A Dahl

Clin Cancer Res· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, pharmacokinetics, and biological pharmacodynamics of the immunocytokine EMD 273066 (huKS-IL2): results of a phase I trial in patients with prostate cancer.
Yoo-Joung Ko, Glenn J Bubley, Robert Weber, Charles Redfern, Daniel P Gold, Thomas Dahl

J Immunother· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capravirine, a nonnucleoside reverse-transcriptase inhibitor in patients infected with HIV-1: a phase 1 study.
Benjamin E Gewurz, Mark Jacobs, Jo Ann Proper, Thomas A Dahl, Tamio Fujiwara

J Infect Dis· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electrostatic interactions lead to the formation of asymmetric collagen-phosphophoryn aggregates.
Thomas Dahl, Arthur Veis

Connect Tissue Res· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dentin matrix protein 1 initiates hydroxyapatite formation in vitro.
Gen He, Thomas Dahl, Arthur Veis, Anne George

Connect Tissue Res· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mineral-related proteins of sea urchin teeth: Lytechinus variegatus.
Arthur Veis, Joseph Barss, Thomas Dahl, Mohammed Rahima, Stuart Stock

Microsc Res Tech· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved circulating half-life and efficacy of an antibody-interleukin 2 immunocytokine based on reduced intracellular proteolysis.
Stephen D Gillies, Kin-Ming Lo, Christa Burger, Yan Lan, Thomas Dahl

Clin Cancer Res· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis